| Jennifer Kaiser, MD | |
|
30 N 1900 E, Salt Lake City, UT 84132-0002 | |
| (801) 581-2401 | |
| Not Available |
| Full Name | Jennifer Kaiser |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 30 N 1900 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164764742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 9149530-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.
Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizer's early-stage compounds, including data from Pfizer's investigational antibody-drug conjugate (ADC) portfolio and research evaluating several molecules targeting novel pathways that play a crucial role in basic cellular functions, at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, IL, from March 31-April 4.
Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project program established under Section 48D of the Internal Revenue Code.
A small but compelling pilot study indicates that many children with serious congenital heart disease, who are typically urged to restrict their activity, can improve their cardiovascular function and exercise capacity through a cardiac rehabilitation program.
Researchers discovered a brain deficiency in people with schizophrenia that could lead to development of new drug therapies.
› Verified 3 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.
Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizer's early-stage compounds, including data from Pfizer's investigational antibody-drug conjugate (ADC) portfolio and research evaluating several molecules targeting novel pathways that play a crucial role in basic cellular functions, at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, IL, from March 31-April 4.
Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project program established under Section 48D of the Internal Revenue Code.
A small but compelling pilot study indicates that many children with serious congenital heart disease, who are typically urged to restrict their activity, can improve their cardiovascular function and exercise capacity through a cardiac rehabilitation program.
Researchers discovered a brain deficiency in people with schizophrenia that could lead to development of new drug therapies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Kaiser, MD 5687 County Road C, Vesper, WI 54489-9619 Ph: (312) 342-2710 | Jennifer Kaiser, MD 30 N 1900 E, Salt Lake City, UT 84132-0002 Ph: (801) 581-2401 |
News Archive
AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.
Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizer's early-stage compounds, including data from Pfizer's investigational antibody-drug conjugate (ADC) portfolio and research evaluating several molecules targeting novel pathways that play a crucial role in basic cellular functions, at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, IL, from March 31-April 4.
Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project program established under Section 48D of the Internal Revenue Code.
A small but compelling pilot study indicates that many children with serious congenital heart disease, who are typically urged to restrict their activity, can improve their cardiovascular function and exercise capacity through a cardiac rehabilitation program.
Researchers discovered a brain deficiency in people with schizophrenia that could lead to development of new drug therapies.
› Verified 3 days ago
Virginia Jean Homewood, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3336 S 4155 W, Ste 301, Salt Lake City, UT 84120 Phone: 801-964-3865 Fax: 801-964-3894 | |
Alexandra L. Woodcock, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2a200, Salt Lake City, UT 84132 Phone: 801-213-3716 | |
Lillian B. Boettcher, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 2b200, Salt Lake City, UT 84132 Phone: 801-581-7647 | |
Patricia Bearnson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4465 S 900 E Ste 275, Salt Lake City, UT 84124 Phone: 801-272-6100 Fax: 801-272-6101 | |
Eric C Nielson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1220 East 3900 South, Suite 3e, Salt Lake City, UT 84124 Phone: 801-685-7188 Fax: 801-685-8116 | |
Susan T Horvath, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1140 E 3900 S Ste 400, Salt Lake City, UT 84124 Phone: 801-262-8666 Fax: 801-263-8821 | |
Carolyn Weaver Swenson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-213-2995 |